Zydus Lifesciences’ New Jersey facility clears USFDA inspection with nil observations

Zydus Lifesciences Ltd on Saturday said the US health regulator has completed an on-site inspection of the pharmacovigilance and post-marketing surveillance system at its office in New Jersey, USA, with nil observations.The inspection by the US Food and Drug Administration (USFDA) was conducted fro…